The safety and efficacy of deep brain stimulation.
Pharmalittle: U.S. pharma layoffs continue to climb; senators push insulin makers for details of low-cost programs
Top of the morning to you, and a fine one it is. Blue skies and cool breezes are enveloping the Pharmalot campus, where the official